Page last updated: 2024-08-24

simendan and Escherichia coli Infections

simendan has been researched along with Escherichia coli Infections in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Paula, M; Delgado, MA; Esteban, A; García-Septien, J; Lorente, JA; Moscoso, A; Nin, N; Perez-Vizcaino, F; Sánchez-Ferrer, A1
Barán, M; Canales, HS; Dubin, A; Edul, VS; Estenssoro, E; Maskin, B; Murias, G; Pozo, MO; Sottile, JP1
Konrad, D; Oldner, A; Rossi, P; Rudehill, A; Wanecek, M; Weitzberg, E1

Other Studies

3 other study(ies) available for simendan and Escherichia coli Infections

ArticleYear
Levosimendan increases portal blood flow and attenuates intestinal intramucosal acidosis in experimental septic shock.
    Shock (Augusta, Ga.), 2010, Volume: 34, Issue:3

    Topics: Acidosis; Animals; Cardiotonic Agents; Cell Hypoxia; Drug Evaluation, Preclinical; Escherichia coli Infections; Heart Rate; Hydrazones; Intestinal Mucosa; Liver Circulation; Microcirculation; Models, Animal; Peritonitis; Portal System; Pyridazines; Shock, Septic; Simendan; Swine; Vasodilator Agents

2010
Effects of levosimendan in normodynamic endotoxaemia: a controlled experimental study.
    Resuscitation, 2006, Volume: 69, Issue:2

    Topics: Acidosis; Animals; Disease Models, Animal; Endotoxemia; Escherichia coli Infections; Hemodynamics; Hydrazones; Intestinal Mucosa; Lactic Acid; Oxygen; Pyridazines; Sheep; Simendan; Vasodilator Agents

2006
Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock.
    Critical care medicine, 2001, Volume: 29, Issue:11

    Topics: Animals; Calcium; Cardiotonic Agents; Escherichia coli Infections; Female; Hemodynamics; Hydrazones; Male; Myocardial Contraction; Pyridazines; Shock, Septic; Simendan; Swine

2001